Disclaimer: Information intended for healthcare professionals only. This Guidelines card, which summarises Scottish Medicines Consortium (SMC) advice on tolvaptan, has been initiated by Otsuka Pharmaceutical (UK) Ltd. Otsuka Pharmaceutical (UK) Ltd has reviewed this card for technical accuracy and regulatory compliance. Otsuka Pharmaceutical (UK) Ltd has provided the supplementary information and prescribing information overleaf. The SMC has reviewed this card for technical accuracy and permission request only. The SMC was not involved in the production of this card.